Could two humans (or two cows) have some differences in their DNA sequences for insulin, yet still make the exact same insulin proteins? Explain.

Could two humans (or two cows) have some differences in their DNA sequences for insulin, yet still make the exact same insulin proteins? Explain

Since Jiskha doesn't have a biology expert at this time, please try posting your question at this site.

http://www.biology-online.org/biology-forum/

In addition, be sure to make really good use of Khan Academy!
http://www.khanacademy.org/science/biology
Click on the Subjects link at the top, and then find the specifics you need within each topic.

Yes, it is possible for two humans or two cows to have differences in their DNA sequences for insulin but still produce the exact same insulin proteins. The DNA sequence for a protein is determined by the sequence of nucleotides in the gene that codes for that protein. However, the genetic code is redundant, meaning that multiple codons can code for the same amino acid.

In the case of insulin, the gene responsible for its production may have different DNA sequences in different individuals due to genetic variations, such as single nucleotide polymorphisms (SNPs) or insertions/deletions. These variations can occur in non-coding regions of the gene or within introns, which do not affect the final protein product.

Furthermore, even if there are differences in the DNA sequence that codes for insulin, it is possible for the variations to result in the same amino acid sequence. This is because the genetic code allows for degeneracy, where multiple codons can code for the same amino acid. For example, the codons GCU, GCC, GCA, and GCG all code for the amino acid alanine.

As a result, even if there are differences in the DNA sequence, the mRNA transcribed from the gene will eventually undergo translation to produce insulin proteins with the same amino acid sequence. This means that despite the genetic variations, two individuals can produce the exact same insulin proteins.

Yes, it is possible for two individuals of the same species to have differences in their DNA sequences for insulin but still produce the exact same insulin proteins. This is due to a phenomenon called redundancy in the genetic code and the process of alternative splicing.

To understand this, we need to first understand the relationship between DNA, RNA, and proteins. DNA contains the instructions for building proteins, and genes are specific sections of DNA that carry these instructions. When a gene is "activated," it is transcribed into a molecule called RNA, specifically messenger RNA (mRNA). mRNA carries the genetic information from the DNA to cellular structures called ribosomes, where proteins are synthesized.

The genetic code is the set of rules that determine how the four nucleotide bases in DNA (adenine, thymine, cytosine, and guanine) are translated into amino acids, the building blocks of proteins. Each three-nucleotide sequence in mRNA, called a codon, codes for a specific amino acid.

Now, let's consider insulin. Insulin is a protein hormone that plays a crucial role in regulating blood sugar levels. The insulin gene contains the instructions for building the insulin protein.

Redundancy in the genetic code means that multiple codons can code for the same amino acid. For example, there are six different codons that all code for the amino acid leucine. This redundancy provides some flexibility in the DNA sequence and allows for genetic variation without affecting the final protein product.

Furthermore, during the process of mRNA processing, a mechanism called alternative splicing can occur. Alternative splicing allows different parts of the mRNA molecule to be combined or rearranged, resulting in different versions of the final protein. In the case of insulin, alternative splicing can lead to the formation of different isoforms, all of which are functional and capable of regulating blood sugar levels.

So, even if two humans or two cows have slightly different DNA sequences in their insulin genes, the redundancy in the genetic code and alternative splicing can result in the production of the exact same insulin proteins. This highlights the versatility and adaptability of the genetic code, allowing for genetic diversity while still maintaining important biological functions.